Skip to main content
SpringerLink
Log in

Platelets and biogenic amines. 2. Indications for a discrete low affinity uptake mechanism shared by norepinephrine and 5-hydroxytryptamine in human platelets

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The uptake of norepinephrine (NE) by human platelets at 10−-9−5×10−-4 M of labelled amine concentration was investigated. At physiological concentrations of NE the uptake was unsaturable and could not be inhibited by imipramine or ouabain. At NE concentrations between 25 and 485 μM the uptake also comprised a saturable component that could be completely blocked by imipramine and partly by ouabain. The saturable uptake of NE had an apparent Km of 273±50 μM and a Vmax of 0.19±0.05 pmole/106 platelets/min. The affinity of NE (IC50) for the 5-HT transporting carrier was 2.3 mM, 8.4 times higher than the apparent Km for saturable NE uptake. The affinity of 5-HT (IC50) for the NE-transporting carrier was 5.8 μM, 5.8 times higher than the apparent Km for saturable 5-HT transport. Imipramine and norzimeldin were equipotent inhibitors of saturable NE uptake, the potency being of the same degree as that for saturable 5-HT uptake. The tertiary amine amitriptyline was 6 times more effective in inhibiting saturable NE uptake than its demethylated product nortriptyline. Nortriptyline and its hydroxylated E- and Z-isomers had a stronger inhibitory effect on saturable NE uptake than on uptake of 5-HT. The results suggest that human platelets possess two separate amine-transporting carriers, both having their highest affinity for 5-HT. The one with the lowest affinity for 5-HT can also accept NE as a substrate. The human platelet does not possess a high-affinity uptake system for NE comparable to that in adrenergic tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abrams WB, Solomon HM (1969) The human platelet as a pharmacologic model for the adrenergic neuron. Clin Pharmacol Ther 10:702–709

    Google Scholar 

  • Athee L, Saarnivaara L (1971) The effect of drugs upon the uptake of 5-hydroxytryptamine and metaraminol by human platelets. J Pharm Pharmacol 23:495–501

    Google Scholar 

  • Bertilsson L, Mellström B, Sjöqvist F (1979) Pronounced inhibition of noradrenalin uptake by 10-hydroxymetabolites of nortriptyline. Life Sci 25:1285–1292

    Google Scholar 

  • Carlsson A, Corrodi H, Fuxe K, Hökfeldt T (1969) Effect of anti-depressant drugs on the depletion of intraneural brain 5-hydroxytryptamine stores caused by 4-methyl-ethyl-meta-tyramine. Eur J Pharmacol 5:357–366

    Google Scholar 

  • Cryer PE (1980) Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med 303:436–444

    Google Scholar 

  • Drummond AH (1976) Interactions of blood platelets with biogenic amines: Uptake, stimulation and receptor binding. In: Gordon JL (ed) Platelets in biology and pathology. Elsevier/North Holland Biomedical Press 8:203–239

  • Esler M, Leonard P, Jackman G, Bobik A, Skews H (1980) Study of noradrenalin uptake and spillover to plasma in normal subjects and patients with essential hypertension. Prog Biochem Pharmacol 17:75–83

    Google Scholar 

  • Feer H (1968) The uptake of serotonin in thrombocytes under influence of metabolic inhibitors. Med exp 18:55–61

    Google Scholar 

  • Garver DL, Davis JM (1979) Minireview: Biogenic amine hypothesis of affective disorders. Life Sci 24:383–394

    Google Scholar 

  • Lingjaerde O (1977) Platelet uptake and storage of serotonin. In: Essman EW (ed) Serotonin in health and disease, Vol. IV. Spectrum Publications, New York, pp 129–199

    Google Scholar 

  • Lingjaerde O, Kildermo O (1981) Dopamine uptake in platelets: Two different low affinity, saturable mechanisms. Agents and Actions 11:410–416

    Google Scholar 

  • Maas JW (1975) Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. Arch Gen Psychiatr 32:1357–1361

    Google Scholar 

  • Malmgren R (1981) Methodological aspects of studies on the 5-HT uptake mechanism in normal platelets. Acta Pharmacol Toxicol 49:277–284

    Google Scholar 

  • Malmgren R (1984) Platelets and biogenic amines. 1. Platelets are poor investigative models for dopamine re-uptake. Psychopharmacology 84:480–485

    Google Scholar 

  • McLean JR, Potoczak D (1969) The effects of sodium and potassium on norepinephrine uptake by rabbit platelets and the inhibition of this process by drugs. Arch Biochem Biophys 132:416–422

    Google Scholar 

  • Peters JR, Grahame-Smith DG (1980) Blood platelets 5-HT-receptors: Characterization and functional association. Eur J Pharmacol 68:243–256

    Google Scholar 

  • Pletscher A, da Prada M, Berneis KH (1971) Aggregation of biogenic monoamines and nucleotides in subcellular storage organelles. Mem Soc Endocrinol 19:767–783

    Google Scholar 

  • Pletscher A, Laubscher A (1980) Blood platelets as models for neurons: Uses and limitations. J Neurol Transm suppl 16:7–16

    Google Scholar 

  • da Prada M, Picotti GB (1979) Content and subcellular localization of catecholamines and 5-hydroxytryptamine in human and animal blood platelets: monoamine distribution between platelets and plasma. Br J Pharmacol 65:653–662

    Google Scholar 

  • van Praag HM (1982) Neurotransmittors and CNS disease. Depression. Lancet 4:1259–1263

    Google Scholar 

  • Quinaux N, Scuvée-Moreau J, Dresse A (1982) Inhibition of in vitro and ex vivo uptake of Noradrenalin and 5-Hydroxytryptamine by five antidepressants; correlation with reduction of spontaneous firing rate of central monoaminergic neurons. Naunyn Schmiedeberg's Arch Pharmacol 319:66–70

    Google Scholar 

  • Shaskan EG, Snyder SH (1970) Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake. J Pharmacol Exp Ther 175:404–418

    Google Scholar 

  • Sneddon JM (1973) Blood platelets as a model for monoamine-containing neurones. In: Kerkut GA, Phillips JW (eds) Progress in neurobiology, vol. 1. Pergamon Press, Oxford, pp 151–192

    Google Scholar 

  • Stahl SM, Meltzer HY (1978) The human platelet as a model for the dopaminergic neuron: Kinetics and pharmacologic properties and the role of the amine storage granules. Exp Neurol 59:1–15

    Google Scholar 

  • Tuomisto J, Tukiainen E, Voutilainen R, Tuomainen P (1980) Inhibition of 5-hydroxytryptamine and norepinephrine uptake in platelets and synaptosomes incubated in plasma from human subjects treated with amitryptiline or nortriptyline: Utilization of the principle for a bioassay method. Psychopharmacology 69:137–142

    Google Scholar 

  • Wilbrandt W, Rosenberg T (1961) The concept of carrier transport and its corollaries in pharmacology. Pharmacol Rev 13:109–183

    Google Scholar 

  • Zivin JA, Wand RD (1982) Minireview: How to analyze binding, enzyme and uptake data: The simplest case, a single phase. Life Sci 30:1407–1422

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Experimental Surgery, Thoracic Clinics, Karolinska Hospital, S-104 01, Stockholm, Sweden

    R. Malmgren

Authors
  1. R. Malmgren
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malmgren, R. Platelets and biogenic amines. 2. Indications for a discrete low affinity uptake mechanism shared by norepinephrine and 5-hydroxytryptamine in human platelets. Psychopharmacology 90, 384–389 (1986). https://doi.org/10.1007/BF00179196

Download citation

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00179196

Key words

Search

Navigation